mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.9 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |